Related Experiment Video
Updated: Jul 9, 2026
05:53
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
MutaGeneSys: estimating individual disease susceptibility based on genome-wide SNP array data
Julia Stoyanovich1, Itsik Pe'er
1Department of Computer Science, Columbia University, 1214 Amsterdam Avenue, New York, NY 10025, USA. jds1@cs.columbia.edu
Bioinformatics (Oxford, England)
|December 1, 2007
Summary
MutaGeneSys is a new system that estimates disease susceptibility using genome-wide genotype data. It integrates multiple data sources to provide disease hypotheses, even with incomplete SNP data.
Area of Science:
- Genomics
- Bioinformatics
- Computational Biology
Background:
- Estimating disease susceptibility is crucial for personalized medicine.
- Existing methods may struggle with incomplete genotype data.
Purpose of the Study:
- To present MutaGeneSys, a novel system for disease susceptibility estimation.
- To integrate diverse genomic and disease databases for enhanced prediction.
Main Methods:
- Utilizes genome-wide genotype data.
- Integrates data from the International HapMap project, whole-genome marker correlation, and the Online Mendelian Inheritance in Man (OMIM) database.
- Accepts SNP data as input to generate disease susceptibility hypotheses.
Main Results:
- MutaGeneSys can deliver disease susceptibility hypotheses even with incomplete SNP data.
- The system is scalable and flexible, providing population, technology, and confidence-specific predictions.
- Predictions are delivered in interactive time.
Conclusions:
- MutaGeneSys offers a robust and flexible approach to disease susceptibility estimation.
- The system's integration of multiple data sources enhances the accuracy and utility of predictions.
- MutaGeneSys is available as an online resource and integrated into the HapMap Genome Browser.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
02:26Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
02:46Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...